TET2 and chronic myelomonocytic leukemia: Apart from FLT3-ITD, loss of TET2 synergizes with other mutations in signal transduction genes such as NRASG12D to induce a fully penetrant CMML phenotype by combined suppression of negative regulators of the RAS pathway [185].